London, 03 July 2015 – Technavio has published a new report on the global opioid-induced constipation market, which is expected to grow at a CAGR of more than 30% from 2015-2019.
About the Report
The new Technavio report draws attention towards the minimal awareness about opioid-induced constipation among patients and the medical fraternity, which have resulted in the use of off-label and over-the-counter medication as the treatment options. The entry of peripherally acting mu-opioid receptor antagonists such as Movantik has driven the market significantly.
“Movantik drugs target the primary cause of opioid-induced constipation without affecting the analgesic action of the opioid drugs, and is becoming the preferred treatment option for opioid-induced constipation,” says Faisal Ghaus, Vice President of Technavio.
The latest report by Technavio also emphasizes oral drugs as one of the safest and the most preferred routes of drug administration as they are more convenient than those administered parenterally.
“Drugs like Movantik and Amitiza are orally administered drugs and have helped in increasing patient compliance, and this trend is expected to continue during the forecast period and boost the market growth,” adds Ghaus.
Market Scope and Calculation of Market Size
The new Technavio report covers the present scenario and growth prospects of the global opioid-induced constipation market from 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of branded, off-label, and OTC drugs used to treat opioid-induced constipation.
Key Information Covered in the Report:
Key Vendors:
- AstraZeneca plc
- Takeda Pharmaceutical Co. Ltd.
- Valeant Pharmaceuticals International Inc.
Market Growth Drivers:
- Unmet Medical Needs
- For a full detailed list, view our report.
Market Challenges:
- Availability of OTC and Off-label Drugs
- For a full detailed list, view our report.
Market Trends:
- Shift toward Targeted Therapy
- For a full detailed list, view our report.
https://www.technavio.com/%3Cp%3E%3Cstrong%3E%3Ca%20href%3D%22http%3A//ww…
